Alaska Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages The Alaska Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is an important legal document that outlines the terms and conditions of sharing and utilizing intellectual property rights, particularly in the field of biomedical research and genetic testing. It establishes a framework for collaboration, innovation, and commercialization for the benefit of both parties involved. This specific Collateral License Agreement aims to facilitate the sharing of knowledge, resources, and expertise between Gentling, Inc. and The University of North Texas Health Science Center in Alaska. By entering into this agreement, both parties agree to work together to contribute to the advancement of scientific research and the development of cutting-edge technologies related to personalized medicine, genetic diagnostics, and biotechnology. The key provisions of the Alaska Collateral License Agreement include the following: 1. Intellectual Property Rights: This agreement identifies and protects the intellectual property rights, including patents, copyrights, trademarks, trade secrets, and know-how that are developed or used during the collaboration between the parties. It establishes the ownership, disclosure, and protection of such intellectual property. 2. License Grants: The agreement grants certain rights and licenses to each party regarding the use of the intellectual property owned by the other party. This allows for the transfer of technology, research materials, and data necessary to implement research projects and commercialize the resulting innovations. 3. Confidentiality and Non-Disclosure: To ensure the confidentiality of proprietary information, this agreement includes provisions for the protection of confidential data exchanged during the collaboration. It sets out the obligations of both parties to maintain the confidentiality of such information and restricts its use to the purposes outlined in the agreement. 4. Governing Law and Dispute Resolution: The agreement specifies that it is governed by the laws of the state of Alaska, establishing the jurisdiction for any legal disputes that may arise between the parties. It also outlines the procedures for resolving disputes, such as negotiations, mediation, or arbitration. 5. Financial Considerations: This section of the agreement details the financial terms and obligations of the parties. It includes provisions for royalty payments, milestone payments, upfront license fees, and other monetary considerations that may result from the commercialization of the intellectual property. While the Alaska Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a specific agreement, there may be different types or variations of such agreements depending on the nature of the collaboration, the scope of research, or the specific intellectual property being licensed. Some other potential types of collateral license agreements include: 1. Exclusive License Agreement: This agreement grants exclusive rights to one party, preventing the licensor from granting similar rights to any other licensee, except for certain exemptions. 2. Non-Exclusive License Agreement: Unlike an exclusive license agreement, this type of agreement allows the licensor to grant licenses to other parties while also allowing the licensee to use the licensed intellectual property rights. 3. Research Collaboration Agreement: This agreement focuses on establishing a joint research collaboration between the parties, allowing them to share and leverage their resources, expertise, and intellectual property for research purposes. These types of collateral license agreements may have slightly different provisions and considerations, which are tailored to the specific needs and goals of the parties involved.

The Alaska Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is an important legal document that outlines the terms and conditions of sharing and utilizing intellectual property rights, particularly in the field of biomedical research and genetic testing. It establishes a framework for collaboration, innovation, and commercialization for the benefit of both parties involved. This specific Collateral License Agreement aims to facilitate the sharing of knowledge, resources, and expertise between Gentling, Inc. and The University of North Texas Health Science Center in Alaska. By entering into this agreement, both parties agree to work together to contribute to the advancement of scientific research and the development of cutting-edge technologies related to personalized medicine, genetic diagnostics, and biotechnology. The key provisions of the Alaska Collateral License Agreement include the following: 1. Intellectual Property Rights: This agreement identifies and protects the intellectual property rights, including patents, copyrights, trademarks, trade secrets, and know-how that are developed or used during the collaboration between the parties. It establishes the ownership, disclosure, and protection of such intellectual property. 2. License Grants: The agreement grants certain rights and licenses to each party regarding the use of the intellectual property owned by the other party. This allows for the transfer of technology, research materials, and data necessary to implement research projects and commercialize the resulting innovations. 3. Confidentiality and Non-Disclosure: To ensure the confidentiality of proprietary information, this agreement includes provisions for the protection of confidential data exchanged during the collaboration. It sets out the obligations of both parties to maintain the confidentiality of such information and restricts its use to the purposes outlined in the agreement. 4. Governing Law and Dispute Resolution: The agreement specifies that it is governed by the laws of the state of Alaska, establishing the jurisdiction for any legal disputes that may arise between the parties. It also outlines the procedures for resolving disputes, such as negotiations, mediation, or arbitration. 5. Financial Considerations: This section of the agreement details the financial terms and obligations of the parties. It includes provisions for royalty payments, milestone payments, upfront license fees, and other monetary considerations that may result from the commercialization of the intellectual property. While the Alaska Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a specific agreement, there may be different types or variations of such agreements depending on the nature of the collaboration, the scope of research, or the specific intellectual property being licensed. Some other potential types of collateral license agreements include: 1. Exclusive License Agreement: This agreement grants exclusive rights to one party, preventing the licensor from granting similar rights to any other licensee, except for certain exemptions. 2. Non-Exclusive License Agreement: Unlike an exclusive license agreement, this type of agreement allows the licensor to grant licenses to other parties while also allowing the licensee to use the licensed intellectual property rights. 3. Research Collaboration Agreement: This agreement focuses on establishing a joint research collaboration between the parties, allowing them to share and leverage their resources, expertise, and intellectual property for research purposes. These types of collateral license agreements may have slightly different provisions and considerations, which are tailored to the specific needs and goals of the parties involved.